Inventor · disambiguated record
Katalin Kariko
Also filed as: KARIKO KATALIN · KARIKÓ KATALIN
22 granted patents·13 pending applications·1,563 citations·filing 2006–2024
96Inventor score
Top patents by PatentIndex Score
35 records- 0198US10232055B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2016·Granted Mar 19, 2019·96 cites·15 claims
- 0298US9012219B2RNA preparations comprising purified modified RNA for reprogramming cellsKARIKO KATALIN·Filed 2010·Granted Apr 21, 2015·116 cites·24 claims
- 0398US8835108B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2013·Granted Sep 16, 2014·207 cites·22 claims
- 0498US8748089B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2013·Granted Jun 10, 2014·227 cites·22 claims
- 0597US10808242B2Method for reducing immunogenicity of RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Oct 20, 2020·11 cites·7 claims
- 0697US9750824B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2014·Granted Sep 5, 2017·59 cites·24 claims
- 0797US8691966B2RNA containing modified nucleosides and methods of use thereofKARIKO KATALIN·Filed 2012·Granted Apr 8, 2014·230 cites·21 claims
- 0897US8278036B2RNA containing modified nucleosides and methods of use thereofKARIKO KATALIN·Filed 2006·Granted Oct 2, 2012·564 cites·21 claims
- 0996US11060107B2Purification and purity assessment of RNA molecules synthesized with modified nucleosidesUNIV PENNSYLVANIA·Filed 2017·Granted Jul 13, 2021·13 cites·7 claims
- 1096US9371511B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2015·Granted Jun 21, 2016·9 cites·16 claims
- 1194US11801314B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2022·Granted Oct 31, 2023·1 cites·27 claims
- 1294US9163213B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2015·Granted Oct 20, 2015·10 cites·21 claims
- 1392US11779659B2RNA constructs and uses thereofBioNTech SE·Filed 2021·Granted Oct 10, 2023·4 cites·22 claims
- 1492US11028370B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2018·Granted Jun 8, 2021·4 cites·20 claims
- 1592US10006007B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2016·Granted Jun 26, 2018·9 cites·19 claims
- 1690US2024226335A9RNA Containing Modified Nucleosides and Methods of Use ThereofUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 1788US11389547B2RNA containing modified nucleosides and methods of use thereofUNIV PENNSYLVANIA·Filed 2019·Granted Jul 19, 2022·1 cites·19 claims
- 1887US11951185B2RNA constructs and uses thereofBioNTech SE·Filed 2021·Granted Apr 9, 2024·1 cites·49 claims
- 1987US2025019719A1Purification and Purity Assessment of RNA Molecules Synthesized with Modified NucleosidesUNIV PENNSYLVANIA·Filed 2024·Application pending·0 cites
- 2085US12460198B2Method for reducing immunogenicity of RNABioNTech SE·Filed 2023·Granted Nov 4, 2025·0 cites·19 claims
- 2185US11739300B2RNA preparations comprising purified modified RNA for reprogramming cellsUNIV PENNSYLVANIA·Filed 2020·Granted Aug 29, 2023·1 cites·14 claims
- 2283US2024390524A1Rna constructs and uses thereofBioNTech SE·Filed 2024·Application pending·0 cites
- 2377US12054734B2Purification and purity assessment of RNA molecules synthesized with modified nucleosidesUNIV PENNSYLVANIA·Filed 2021·Granted Aug 6, 2024·0 cites·7 claims
- 2472US11873478B2Method for reducing immunogenicity of RNABioNTech SE·Filed 2020·Granted Jan 16, 2024·0 cites·20 claims
- 2569US2024018486A1Rna preparations comprising purified modified rna for reprogramming cellsUNIV PENNSYLVANIA·Filed 2023·Application pending·0 cites
- 2665US2016032316A1Purification and Purity Assessment of RNA Molecules Synthesized with Modified NucleosidesUNIV PENNSYLVANIA·Filed 2014·Application pending·0 cites
- 2765US2025101499A1Analysis of rna molecules using catalytic nucleic acidsBioNTech SE·Filed 2023·Application pending·0 cites
- 2860US12281138B25′-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing RNA, expressing proteins in therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2019·Granted Apr 22, 2025·0 cites·69 claims
- 2960US2025122546A1Rna constructs and uses thereofBioNTech SE·Filed 2022·Application pending·0 cites
- 3059US2021340170A15'-cap compounds and their uses in stabilizing rna, expressing proteins and in therapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Application pending·0 cites
- 3157US2025375534A1Complexes for delivery of nucleic acidsBioNTech SE·Filed 2023·Application pending·0 cites
- 3257US2024408032A1Lipid-based rna formulations suitable for therapyBioNTech SE·Filed 2022·Application pending·0 cites
- 3354US2025009780A1Agents encoding cldn6 and cd3 binding elements for treating cldn6-positive cancersBioNTech SE·Filed 2022·Application pending·0 cites
- 3449US2016030527A1Compositions and Methods for Treatment of StrokeUNIV PENNSYLVANIA·Filed 2014·Application pending·0 cites
- 3547US2019153425A1Methods for Providing Single-Stranded RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Katalin Kariko files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →